What is the recommended dose of epinephrine (adrenaline) via an auto-injector, such as an EpiPen (epinephrine), for chemotherapy-induced anaphylaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Epinephrine Dosing for Chemotherapy-Induced Anaphylaxis

For chemotherapy-induced anaphylaxis, administer epinephrine 0.3-0.5 mg (0.3-0.5 mL of 1:1000 concentration) intramuscularly in the anterolateral thigh for adults and children ≥30 kg, or 0.01 mg/kg (maximum 0.3 mg) for children <30 kg. 1

Dosing Guidelines

Adults and Children ≥30 kg (66 lbs):

  • 0.3-0.5 mg (0.3-0.5 mL) of 1:1000 concentration epinephrine
  • Administer intramuscularly in the anterolateral thigh
  • Maximum 0.5 mg per injection
  • May repeat every 5-10 minutes as necessary based on clinical response 1

Children <30 kg (66 lbs):

  • 0.01 mg/kg (0.01 mL/kg) of 1:1000 concentration epinephrine
  • Administer intramuscularly in the anterolateral thigh
  • Maximum 0.3 mg per injection
  • May repeat every 5-10 minutes as necessary based on clinical response 1

Administration Technique

  • Inject through clothing if necessary
  • For children, hold the leg firmly in place to minimize risk of injection-related injury 1
  • Use a needle long enough (at least 1/2 inch to 5/8 inch) to ensure intramuscular delivery 1
  • Do not administer repeated injections at the same site to avoid tissue necrosis from vasoconstriction 1

Important Clinical Considerations

  • Intramuscular injection in the lateral thigh (vastus lateralis) is the preferred route for first-aid treatment of anaphylaxis 2
  • Studies have shown that intramuscular injection in the lateral thigh leads to faster peak plasma epinephrine concentrations (8 ± 2 minutes) compared to subcutaneous injection (34 ± 14 minutes) 2
  • Monitor the patient clinically for severity of the allergic reaction and potential cardiac effects 1
  • Prepare for a second dose if symptoms persist or worsen after 5-15 minutes 3
  • Between 6-19% of patients require a second dose of epinephrine 3

Auto-Injector Selection

When using auto-injectors for chemotherapy-induced anaphylaxis:

  • For adults and children ≥30 kg: Use 0.3 mg epinephrine auto-injector
  • For children 15-30 kg: Use 0.15 mg epinephrine auto-injector
  • For infants and small children 7.5-15 kg: Use 0.1 mg epinephrine auto-injector (if available) 3, 4

Cautions and Monitoring

  • Inspect solution visually before administration; do not use if colored, cloudy, or contains particulate matter 1
  • Monitor vital signs, including blood pressure, heart rate, and oxygen saturation 3
  • Position patients with hypotension in a supine position with legs elevated 3
  • Administer fluid resuscitation (1-2 liters of normal saline at 5-10 mL/kg) for hypotensive patients 3
  • Provide supplemental oxygen for patients with respiratory symptoms or those receiving multiple doses of epinephrine 3

Follow-up Care

  • Observe patients for at least 4-6 hours after chemotherapy-induced anaphylaxis due to risk of biphasic reactions 3
  • High-risk patients may require extended observation up to 6 hours or longer, including hospital admission 3
  • Consider referral to an allergist/immunologist for identification of triggers and long-term management 3

Remember that while antihistamines and glucocorticoids may be used as adjunctive therapy, they should never delay or replace epinephrine administration, which remains the cornerstone of anaphylaxis management 3, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Anaphylaxis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Epinephrine, auto-injectors, and anaphylaxis: Challenges of dose, depth, and device.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2018

Research

Epinephrine in the Management of Anaphylaxis.

The journal of allergy and clinical immunology. In practice, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.